摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[3-(3,7-Dimethylocta-2,6-dienyl)-4,5-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one

中文名称
——
中文别名
——
英文名称
2-[3-(3,7-Dimethylocta-2,6-dienyl)-4,5-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one
英文别名
——
2-[3-(3,7-Dimethylocta-2,6-dienyl)-4,5-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one化学式
CAS
——
化学式
C25H28O6
mdl
——
分子量
424.5
InChiKey
AMSGNHVRVKYLPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.8
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    107
  • 氢给体数:
    4
  • 氢受体数:
    6

文献信息

  • Flavanone compound and uses thereof
    申请人:POKKA CORPORATION
    公开号:EP2186806A1
    公开(公告)日:2010-05-19
    Each of an antioxidant, an antimicrobial agent, an antitumor agent, a food and beverage product, cosmetics, a quasi-drug and a pharmaceutical of the present invention contains a new flavanone compound represented by the following structural formula: Alternatively, each of an antioxidant, an antimicrobial agent, an antitumor agent, a food and beverage product, cosmetics, a quasi-drug and a pharmaceutical of the present invention contains at least one flavanone compound selected from the group consisting of nymphaeol-A, nymphaeol-B, and nymphaeol-C.
    本发明的抗氧化剂、抗菌剂、抗肿瘤剂、食品和饮料产品、化妆品、准药物和药品中的每一种都含有由以下结构式表示的新黄酮化合物: 或者,本发明的抗氧化剂、抗菌剂、抗肿瘤剂、食品和饮料产品、化妆品、准药品和药品中的每一种都含有至少一种选自蛱蝶醇-A、蛱蝶醇-B 和蛱蝶醇-C 所组成的组的黄烷酮化合物。
  • PERIODONTAL BACTERIAL GROWTH INHIBITOR, ORAL HYGIENE PRODUCT, AND FOOD AND DRINK
    申请人:POKKA CORPORATION
    公开号:EP2216037A1
    公开(公告)日:2010-08-11
    A periodontal bacterial growth inhibitor contains as an active ingredient a Macaranga tanarius extract extracted from Macaranga tanarius with an extraction solvent including at least an organic solvent. Alternatively, the periodontal bacterial growth inhibitor contains as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C. The periodontal bacterial growth inhibitor is used by being blended to, for example, an oral hygiene product or a food and drink.
    一种牙周细菌生长抑制剂的有效成分是用至少包括一种有机溶剂的萃取溶剂从Macaranga tanarius中提取的Macaranga tanarius萃取物。或者,牙周细菌生长抑制剂含有至少一种选自蛱蝶醇-A、蛱蝶醇-B 和蛱蝶醇-C 的活性成分。牙周细菌生长抑制剂可混入口腔卫生产品或食品饮料等中使用。
  • ANTI-METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AGENT AND ANTI-VANCOMYCIN-RESISTANT ENTEROCOCCUS AGENT
    申请人:POKKA CORPORATION
    公开号:EP2251023A1
    公开(公告)日:2010-11-17
    An anti-methicillin-resistant Staphylococcus aureus agent (anti-MRSA agent) and an anti-vancomycin-resistant Enterococcus agent (anti-VRE agent) contain as an active ingredient an Oobagi extract extracted from Oobagi with an extraction solvent including at least an organic solvent. Alternatively, the anti-MRSA agent and the anti-VRE agent contain as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C.
    一种抗耐甲氧西林黄色葡萄球菌制剂(抗 MRSA 制剂)和一种抗耐万古霉素肠球菌制剂(抗 VRE 制剂)的活性成分是用至少包括一种有机溶剂的提取溶剂从 Oobagi 提取的 Oobagi 提取物。或者,抗耐万古霉素肠球菌药剂和抗耐万古霉素肠球菌药剂含有至少一种选自莕菜醇-A、莕菜醇-B 和莕菜醇-C 的活性成分。
  • INHIBITOR FOR GROWTH OF BACTERIA OF GENUS LEGIONELLA, BATH AGENT AND CLEANING AGENT
    申请人:POKKA CORPORATION
    公开号:EP2255624A1
    公开(公告)日:2010-12-01
    A growth inhibitor of bacteria of the genus Legionella contains as an active ingredient a Macaranga tanarius extract extracted from Macaranga tanarius with an extraction solvent including at least an organic solvent. Alternatively, the growth inhibitor of bacteria of the genus Legionella contains as an active ingredient at least one selected from nymphaeol-.A, nymphaeol-B, and nymphaeol-C. The growth inhibitor of bacteria of the genus Legionella is used by being blended to, for example, a bath agent or a cleaning agent.
    军团菌属细菌生长抑制剂的有效成分是用至少包括一种有机溶剂的萃取溶剂从马卡连柯(Macaranga tanarius)中萃取的马卡连柯(Macaranga tanarius)。或者,军团菌属细菌的生长抑制剂含有至少一种选自 nymphaeol-.A、nymphaeol-B 和 nymphaeol-C 的活性成分。军团菌属细菌生长抑制剂可与沐浴剂或清洁剂等混合使用。
  • Prenylflavanone compounds for modulating diabetes
    申请人:NatureWise Biotech & Medicals Corporation
    公开号:EP2783684A1
    公开(公告)日:2014-10-01
    The present invention is directed to a novel use of prenylflavanone compounds for control of blood glucose and treatment or prevention of diabetes.
    本发明涉及一种控制血糖和治疗或预防糖尿病的前黄烷酮化合物的新用途。
查看更多